Methicillin-resistant Staphylococcus aureus nosocomial infection trends in Hospital Universiti Sains Malaysia during 2002-2007

Annals of Saudi Medicine

Volumn 30, Issue 5, 2010, Pages

  Al Talib, Hassanain ^a   Yean, Chan ^a   Al Jashamy, Karim ^b   Hasan, Habsah ^a  

^a SCHOOL OF HEALTH SCIENCES   (Malaysia)

^b MANAGEMENT AND SCIENCE UNIVERSITY   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION RATE; INTENSIVE CARE UNIT; INVASIVE PROCEDURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALAYSIA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; ORTHOPEDICS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; SURGICAL WARD; UNIVERSITY HOSPITAL;

ADULT; ANTI-BACTERIAL AGENTS; CROSS INFECTION; DISEASE TRANSMISSION, INFECTIOUS; ERYTHROMYCIN; FEMALE; GENTAMICINS; HOSPITALS; HUMANS; INCIDENCE; LENGTH OF STAY; LOGISTIC MODELS; MALAYSIA; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; PENICILLIN G; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; VANCOMYCIN;

EID: 77956258742     PISSN: 02564947     EISSN: 09754466     Source Type: Journal    
DOI: 10.4103/0256-4947.67077     Document Type: Article

References (39)

1. Available from: http://www.phac-aspc.gc.ca/nois-sinp/reports-rapport/ mrsa-sarm-result-eng.phphttp://www.phac-aspc.gc.ca/nois-sinp/reports-rapport/ mrsa-sarm-result-eng.php [last accessed on 2009 Nov 20]
2. Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, et al. Survey of infections due to Staphylococcus species: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001;32:S114-32.
3. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995;274:639-44.
4. Berthelot P, Grattard F, Fascia P, Fichtner C, Moulin M, Lavocat MP, et al. Implication of a healthcare worker with chronic skin disease in the transmission of an epidemic strain of methicillin-resistant Staphylococcus aureus in a pediatric intensive care unit. Infect Control Hosp Epidemiol 2003;24:299-300.
5. Saiman L, Cronquist A, Wu F, Zhou J, Rubenstein D, Eisner W, Kreiswirth BN, et al. An outbreak of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2003;24:317-21.
6. Nimmo GR, Pearson JC, Collignon PJ, Christiansen KJ, Coombs GW, Bell JM, et al. Prevalence of MRSA among Staphylococcus aureus isolated from hospital inpatients, 2005: report from the Australian Group for Antimicrobial Resistance. Commun Dis Intell 2007;31:288-96.
7. Spurgeon D. Prevalence of MRSA in US hospitals hits new high. BMJ 2007;335:961.
8. Rohani MY, Raudzah A, Lau MG, Zaidatul AA, Salbiah MN, Keah KC, et al. Susceptibility pattern of Staphylococcus aureus isolated in Malaysian hospitals. Int J Antimicrob Agents 2000;13:209-13.
9. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005;26:166-74.
10. Shorr AF, Combes A, Kollef MH, Chastre J. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy. Crit Care Med 2006;34:700-6.
11. Brumfitt W, Hamilton-Miller J. Methicillin-resistant Staphylococcus aureus. N Engl J Med 1989;320:1188-96.
12. Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, et al. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med 1999;340:493-501.
13. Centers for Disease Control and Prevention. Guidelines for prevention of nosocomial pneumonia. Infect Control Hosp Epidemiol 1994;15:587-627.
14. Available from: http://www.cdc.gov/ncidod/dhqp/nnis.html [cited in; 2009]
15. Garner JS, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. In: Olmsted R, editor. APIC Infection Control and Applied Epidemiology: Principles and Practice. St. Louis: Mosby; 1996. p. A1-20.
16. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 15th informational supplement M100-S15. Wayne, PA: Clinical and Laboratory Standards Institute; 2005.
17. Nigel Bruce DPaDS. Quantitative methods for health research a practical interactive guide to epidemiology and statistics. Chichester: John Wiley and Sons Ltd; 2008. p. 16.
18. Al-Talib H, Yean CY, Al-Khateeb A, Hassan H, Singh KK, Al-Jashamy K, et al. A pentaplex PCR assay for the rapid detection of methicillin-resistant Staphylococcus aureus and Panton-Valentine Leucocidin. BMC Microbiol 2009;9:113.
19. Kluytmans-Vandenbergh MF, Kluytmans JA. Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives. Clin Microbiol Infect 2006;12:9-15.
20. Cheong I, Tan SC, Wong YH, Zainudin BM, Rahman MZ. Methicillin-resistant Staphylococcus aureus (mrsa) in a Malaysian hospital. Med J Malaysia 1994;49:24-8.
21. Barakate MS, Yang YX, Foo SH, Vickery AM, Sharp CA, Fowler LD, et al. An epidemiological survey of methicillin-resistant Staphylococcus aureus in a tertiary referral hospital. J Hosp Infect 2000;44:19-26.
22. Bell JM, Turnidge JD; SENTRY APAC. High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia-Pacific and South Africa: results from SENTRY antimicrobial surveillance program, 1998-1999. Antimicrob Agents Chemother 2002;46:879-81.
23. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 2002;162:2229-35.
24. Wang FD, Chen YY, Chen TL, Liu CY. Risk factors and mortality in patients with nosocomial Staphylococcus aureus bacteremia. Am J Infect Control 2008;36:118-22.
25. Oztoprak N, Cevik MA, Akinci E, Korkmaz M, Erbay A, Eren SS, et al. Risk factors for ICU-acquired methicillin-resistant Staphylococcus aureus infections. Am J Infect Control 2006;34:1-5.
26. Schaefer AM, McMullen KM, Mayfield JL, Richmond A, Warren DK, Dubberke ER. Risk factors associated with methicillin-resistant Staphylococcus aureus colonization on hospital admission among oncology patients. Am J Infect Control 2009;37:603-5.
27. Dziekan G, Hahn A, Thne K, Schwarzer G, Schfer K, Daschner FD, et al. Methicillin-resistant Staphylococcus aureus in a teaching hospital: investigation of nosocomial transmission using a matched case-control study. J Hosp Infect 2000;46:263-70.
28. Graffunder EM, Venezia RA. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 2002;49:999-1005.
29. Huang SS, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 2003;36:281-5.
30. Jernigan JA, Pullen AL, Flowers L, Bell M, Jarvis WR. Prevalence of and risk factors for colonization with methicillin-resistant Staphylococcus aureus at the time of hospital admission. Infect Control Hosp Epidemiol 2003;24:409-14.
31. Corea E, de Silva T, Perera J. Methicillin-resistant Staphylococcus aureus: prevalence, incidence and risk factors associated with colonization in Sri Lanka. J Hosp Infect 2003;55:145-8.
32. Albrich WC, Harbarth S. Health-care workers: source, vector, or victim of MRSA? Lancet Infect Dis 2008;8:289-301.
33. Girou E, Pujade G, Legrand P, Cizeau F, Brun-Buisson C. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis 1998;27:543-50.
34. Pujol M, Pea C, Pallares R, Ariza J, Ayats J, Dominguez MA, et al. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 1996;100:509-16.
35. Akpaka PE, Kissoon S, Swanston WH, Monteil M. Prevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus isolates from Trinidad and Tobago. Ann Clin Microbiol Antimicrob 2006;5:16.
36. Orrett FA, Land M. Methicillin-resistant Staphylococcus aureus prevalence: current susceptibility patterns in Trinidad. BMC Infect Dis 2006;6:83.
37. Daum TE, Schaberg DR, Terpenning MS, Sottile WS, Kauffman CA. Increasing resistance of Staphylococcus aureus to ciprofloxacin. Antimicrob Agents Chemother 1990;34:1862-3.
38. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997;40:135-6.
39. Tenover FC. Implications of vancomycin-resistant Staphylococcus aureus. J Hosp Infect 1999;43:S3-7.